San Joaquin Accident And Medical Group, Inc. | |
4559 N Cedar Ave Fresno CA 93726-2540 | |
(559) 222-3400 | |
(559) 222-6515 |
Full Name | San Joaquin Accident And Medical Group, Inc. |
---|---|
Speciality | Clinic/center - Multi-specialty |
Location | 4559 N Cedar Ave, Fresno, California |
Authorized Official Name and Position | John Brent Arakelian (PRESIDENT) |
Authorized Official Contact | 5592223400 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
San Joaquin Accident And Medical Group, Inc. 4559 N Cedar Ave Fresno CA 93726-2540 Ph: (559) 222-3400 | San Joaquin Accident And Medical Group, Inc. 4559 N Cedar Ave Fresno CA 93726-2540 Ph: (559) 222-3400 |
NPI Number | 1033318464 |
---|---|
Provider Enumeration Date | 07/16/2007 |
Last Update Date | 07/16/2007 |
Identifier | Type | State | Issuer |
---|---|---|---|
1033318464 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Primary |
News Archive
Scientists at the University of Nebraska Medical Center in Omaha and Columbia University Medical Center in New York have discovered a new vaccine approach that successfully prevents the death of brain cells in a mouse model of Parkinson's disease.
Yale University researchers have found that a single molecule not only connects brain cells but also changes how we learn. The findings, reported in the December 9 issue of the journal Neuron, may help researchers discover ways to improve memory and could lead to new therapies to correct neurological disorders.
The Center for Health Value Innovation, the nation's premier information exchange for value-based design, today joined with other non-profits, healthcare provider groups, universities, government officials, and corporations to fully support the National Diabetes Goal (NDG) which aims to increase awareness and improve the management of type 2 Diabetes to the 45 percent of Americans at risk.
Eli Lilly and Company today announced that the U.S. Food and Drug Administration has assigned Priority Review to the regulatory submission for ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial chemotherapy.
› Verified 8 days ago
Sante' Foundation Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7370 N Palm Ave Ste 101, Fresno, CA 93711 Phone: 559-228-5400 | |
Sequoia Community Health Centers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 302 Fresno St Ste 102, Fresno, CA 93706 Phone: 559-457-5700 Fax: 559-457-5790 | |
Fresno Healthcare Center, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3233 N Chestnut Ave Ste 102, Fresno, CA 93726 Phone: 559-456-1167 Fax: 559-456-1183 | |
Planned Parenthood Mar Monte, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 6095 N 1st St, Fresno, CA 93710 Phone: 559-446-1515 Fax: 559-446-1273 | |
Valley Pediatric Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7130 N Sharon Ave Ste 101, Fresno, CA 93720 Phone: 559-436-8606 Fax: 559-436-8654 | |
Dizon Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7035 N Maple Ave Ste 102b, Fresno, CA 93720 Phone: 559-299-2997 | |
United Health Centers Of The San Joaquin Valley Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2630 Tuolumne St, Fresno, CA 93721 Phone: 800-492-4227 Fax: 559-646-6614 |